Our Pricing

Complete Guide: How to Get Mounjaro UK in 2025

Understanding how to get Mounjaro UK starts with knowing the eligibility criteria and prescription requirements for this dual GIP/GLP-1 receptor agonist. At Cured Pharmacy, we've helped thousands of patients access genuine UK-licensed Mounjaro (tirzepatide) through our streamlined online consultation process, with transparent pricing from £135.00 and prescriptions issued by UK-registered clinicians within hours.

Who Is Eligible for Mounjaro in the UK?

To get Mounjaro UK, you must meet specific clinical criteria established by the MHRA and NICE guidelines [1]. The medication is licensed for adults with a body mass index (BMI) of 30 kg/m² or above, or a BMI of 27 kg/m² or above if you have at least one weight-related health condition such as type 2 diabetes, hypertension, or obstructive sleep apnoea [2].

Our UK prescribers assess each patient individually during the online consultation, reviewing your medical history, current medications, and weight loss goals. Mounjaro is not suitable for everyone — contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease [3]. Pregnant or breastfeeding women cannot use tirzepatide, and the medication requires careful consideration in patients with a history of pancreatitis.

The consultation process at Cured Pharmacy takes under three minutes to complete online. You'll answer questions about your weight history, previous weight loss attempts, current health conditions, and medications. A UK-registered prescriber reviews your assessment the same day, and if clinically appropriate, issues a prescription that our pharmacy team dispenses directly to your door in discreet packaging.

BMI Requirements and Health Conditions

Your BMI calculation forms the foundation of Mounjaro eligibility. For patients with a BMI between 27-29.9 kg/m², you must have documented weight-related comorbidities to qualify. These include cardiovascular disease, fatty liver disease, polycystic ovary syndrome, or diagnosed prediabetes [2]. Patients with a BMI of 30 kg/m² or higher may be considered eligible based on BMI alone, though prescribers still evaluate your complete medical profile to ensure safe prescribing.

How to Get Mounjaro UK: The Online Prescription Process

Accessing Mounjaro through Cured Pharmacy follows a straightforward four-step process designed to meet all UK regulatory requirements whilst providing maximum convenience. First, you complete our confidential online medical questionnaire, which our clinical team reviews against current MHRA prescribing guidelines for tirzepatide. Second, a UK-registered prescriber assesses your suitability, typically within 2-4 hours during working days.

If approved, your prescription is sent electronically to our GPhC-registered pharmacy (registration number 9012511), where our team dispenses genuine Mounjaro KwikPens sourced directly from licensed UK wholesalers. We never supply grey-market or imported versions. Finally, your medication is dispatched via tracked courier in completely unmarked packaging, arriving within 1-2 working days across the UK.

The entire process from consultation to delivery typically takes 2-3 working days. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees every prescription to ensure clinical appropriateness and patient safety. You'll receive comprehensive injection technique guidance, storage instructions, and direct access to our pharmacy team for any questions during your treatment journey.

Mounjaro Pricing and Dosing Schedule

Mounjaro is available at Cured Pharmacy from £135.00 with transparent pricing displayed before you complete your consultation. The medication follows a structured dose escalation schedule designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes [1]. Treatment begins with a 2.5 mg weekly injection for four weeks, increasing to 5 mg for the next four weeks.

Based on your response and tolerability, your prescriber may continue escalating the dose every four weeks through 7.5 mg, 10 mg, 12.5 mg, and up to the maximum maintenance dose of 15 mg weekly. In the SURPASS-2 trial, patients on the 15 mg dose achieved an average body weight reduction of 22.5% over 72 weeks, compared to 9.3% with semaglutide 1 mg [1][4]. Not all patients require the maximum dose — your UK prescriber will determine the optimal maintenance dose based on your individual response.

Each Mounjaro KwikPen contains four weekly doses at the prescribed strength. You'll need a new pen each month, and our pharmacy team can arrange automatic monthly refills subject to ongoing prescriber approval. The medication requires refrigeration between 2-8°C until first use, though unopened pens can be stored at room temperature (up to 30°C) for up to 21 days if needed.

Dose Escalation and Treatment Duration

The gradual dose increase protocol is clinically important for tolerability. Rushing through dose escalation significantly increases the risk of nausea, vomiting, and diarrhoea — the most commonly reported side effects in clinical trials [3]. Your prescriber may pause dose escalation or reduce the dose if you experience persistent gastrointestinal symptoms. Most patients reach their maintenance dose within 16-20 weeks of starting treatment, at which point weight loss typically accelerates before plateauing around 60-72 weeks [1].

How to Get Mounjaro UK Compared to Other Weight Loss Treatments

When deciding how to get Mounjaro UK versus alternative treatments, understanding the mechanistic differences helps inform your choice. Mounjaro (tirzepatide) is the only dual GIP/GLP-1 receptor agonist licensed for weight management, meaning it activates two complementary hormone pathways that regulate appetite, glucose metabolism, and energy expenditure [1]. This dual action produces superior weight loss compared to single-pathway GLP-1 agonists in head-to-head trials.

Wegovy (semaglutide) is the most comparable alternative, also delivered as a weekly injection. In the STEP 1 trial, semaglutide 2.4 mg produced an average 14.9% body weight reduction over 68 weeks [5]. Whilst highly effective, this is notably less than the 22.5% average reduction seen with tirzepatide 15 mg in SURPASS-3 [1]. However, Wegovy is available at a lower starting price point and may be preferable for patients who respond well to GLP-1 therapy alone.

Saxenda (liraglutide) requires daily injections and typically produces more modest weight loss of 5-10% body weight [2]. Oral treatments like Orlistat work through a completely different mechanism — blocking fat absorption in the gut — and produce average weight loss of 3-5% when combined with dietary changes [2]. Your UK prescriber will discuss which option aligns best with your medical history, lifestyle preferences, and weight loss targets during your consultation.

What to Expect During Mounjaro Treatment

Most patients notice reduced appetite within the first week of starting Mounjaro, though measurable weight loss typically becomes apparent after 4-6 weeks of treatment [1]. The medication works by slowing gastric emptying, enhancing insulin secretion in response to meals, and acting on brain regions that regulate hunger and satiety. You'll likely feel fuller after smaller portions and experience fewer cravings between meals.

Gastrointestinal side effects are the most common initial experience, affecting up to 20-30% of patients in clinical trials [3]. Nausea is usually mild to moderate and diminishes significantly after the first month as your body adjusts to each new dose. Eating smaller, more frequent meals and avoiding high-fat foods can help manage these symptoms. Serious side effects are rare but include potential risk of pancreatitis, gallbladder problems, and hypoglycaemia if you're taking other diabetes medications [3].

Regular follow-up with your prescriber is essential throughout treatment. At Cured Pharmacy, we recommend check-ins every 8-12 weeks to assess your progress, adjust dosing if needed, and monitor for any concerning symptoms. Mounjaro is most effective when combined with sustainable lifestyle modifications — our clinical team provides guidance on nutrition and physical activity strategies that complement your medication. Treatment duration varies by individual, but most patients continue for 12-18 months to achieve and consolidate their weight loss goals.

Injection Technique and Storage

Mounjaro KwikPens are designed for subcutaneous injection into the abdomen, thigh, or upper arm. The pen mechanism is pre-filled and requires no manual dose setting — you simply attach a new pen needle, select your injection site, press the pen firmly against your skin, and press the dose button until you hear a click. The injection takes approximately 5-10 seconds. Rotate injection sites each week to prevent lipohypertrophy (fatty lumps under the skin). Store unused pens in the refrigerator and allow them to reach room temperature for 30 minutes before injecting to reduce injection site discomfort.

How to Get Mounjaro UK: NHS vs Private Prescription Routes

Mounjaro is available through both NHS and private prescription routes in the UK, though access criteria differ significantly. NHS England currently restricts tirzepatide prescribing to specialist weight management services in limited areas, with strict eligibility requirements including BMI ≥35 kg/m² with comorbidities or BMI ≥40 kg/m², plus documented participation in tier 3 weight management programmes [2]. Waiting times for NHS specialist services often exceed 12-18 months in many regions.

Private online pharmacies like Cured Pharmacy offer faster access through remote consultations with UK-registered prescribers who follow MHRA licensing criteria. The eligibility threshold is typically lower (BMI ≥27 kg/m² with comorbidities or ≥30 kg/m² without), and you can complete the entire process from home without GP referral. All prescribing decisions remain clinically governed — our prescribers decline approximately 15-20% of applications where Mounjaro is not clinically appropriate or safer alternatives exist.

Private prescription costs include both the consultation fee (free at Cured Pharmacy) and medication cost. Whilst NHS prescriptions would only incur the standard prescription charge (currently £135.00 in England), the limited availability means most patients seeking Mounjaro currently access it privately. Our transparent pricing model shows exact costs before you start your consultation, with no hidden fees or subscription requirements. You pay only for the medication you receive, and you can pause or stop treatment at any time without penalty.

Prescriber Qualifications and Safety Oversight

Every Mounjaro prescription issued through Cured Pharmacy is reviewed and authorised by a UK-registered prescriber — either a GMC-registered doctor or an independent prescriber pharmacist. Our clinical team undergoes regular training on obesity medicine, GLP-1 therapy, and adverse event management. We maintain detailed clinical records for every patient and operate under the supervision of our superintendent pharmacist, Tarun Kumar (GPhC 2233073), who ensures all prescribing aligns with current NICE guidance and MHRA safety updates [2][3].

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (Clinical guideline CG189). NICE. https://www.nice.org.uk/guidance/cg189
3. NHS. (2024). Tirzepatide. NHS UK. https://www.nhs.uk/medicines/tirzepatide/
4. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
5. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro (tirzepatide) is a prescription-only medicine that may not be suitable for everyone. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment and lifestyle modifications.